	营业费用		日
AbbVie	USD 10.27B	538M	2026-03
Alterity Therapeutics Limited	AUD 8.67M	893.38K	2025-12
Amgen	USD 4.78B	1.12B	2026-03
AstraZeneca	USD 8.18B	4.35B	2026-03
Bristol-Myers Squibb	USD 20.07B	11.77B	2026-03
Cipla	INR 60.98B	1.06B	2025-12
Clal Biotechnology	ILS 5.15M	9.47M	2022-12
Compugen	USD 11.29M	1.51M	2025-12
CSL	USD 5.7B	2.82B	2025-12
Eisai	JPY 199.9B	16.22B	2025-12
Eli Lilly	USD 10.02B	285M	2026-03
Gilead Sciences	USD 23.52B	18.55B	2026-03
GlaxoSmithKline	GBP 5.34B	1.85B	2026-03
Grifols	EUR 1.99B	217.4M	2025-12
Incyte	USD 5.62B	4.5B	2026-03
Infinity Pharmaceuticals	USD 10.7M	1.54M	2023-06
Ionis Pharmaceuticals	USD 364M	54M	2026-03
J&J	USD 17.44B	1.53B	2026-03
Novartis	USD 9.29B	507M	2026-03
Pfizer	USD 90.1B	77.19B	2026-03
Plus Therapeutics	USD 7.11M	1.23M	2025-12
Roche Holding	CHF 21.01B	10.84B	2025-12
TG Therapeutics	USD 170.12M	28.04M	2026-03